Publikation
Milk intake and incident stroke and CHD in populations of European descent: a Mendelian randomisation study.
Wissenschaftlicher Artikel/Review - 21.10.2021
Vissers L E T, Sluijs Ivonne, Burgess Stephen, Forouhi N G, Freisling Heinz, Imamura F, Nilsson T K, Renström Frida, Weiderpass Elisabete, Aleksandrova K, Dahm C C, Perez-Cornago A, Schulze M B, Tong T Y N, Aune Dagfinn, Bonet Catalina, Boer J M A, Boeing Heiner, Chirlaque M D, Conchi M I, Imaz L, Jäger S, Krogh V, Kyrø C, Masala G, Melander O, Overvad Kim, Panico Salvatore, Sánches M J, Sonestedt Emily, Tjønneland Anne, Tzoulaki Ioanna, Verschuren W M Monique, Riboli Elio, Wareham N J, Danesh John, Butterworth A S, van der Schouw Y T
Bereiche
PubMed
DOI
Kontakt
Zitation
Art
Zeitschrift
Veröffentlichungsdatum
eISSN (Online)
Seiten
Kurzbeschreibung/Zielsetzung
Higher milk intake has been associated with a lower stroke risk, but not with risk of CHD. Residual confounding or reverse causation cannot be excluded. Therefore, we estimated the causal association of milk consumption with stroke and CHD risk through instrumental variable (IV) and gene-outcome analyses. IV analysis included 29 328 participants (4611 stroke; 9828 CHD) of the European Prospective Investigation into Cancer and Nutrition (EPIC)-CVD (eight European countries) and European Prospective Investigation into Cancer and Nutrition-Netherlands (EPIC-NL) case-cohort studies. rs4988235, a lactase persistence (LP) SNP which enables digestion of lactose in adulthood was used as genetic instrument. Intake of milk was first regressed on rs4988235 in a linear regression model. Next, associations of genetically predicted milk consumption with stroke and CHD were estimated using Prentice-weighted Cox regression. Gene-outcome analysis included 777 024 participants (50 804 cases) from MEGASTROKE (including EPIC-CVD), UK Biobank and EPIC-NL for stroke, and 483 966 participants (61 612 cases) from CARDIoGRAM, UK Biobank, EPIC-CVD and EPIC-NL for CHD. In IV analyses, each additional LP allele was associated with a higher intake of milk in EPIC-CVD ( = 13·7 g/d; 95 % CI 8·4, 19·1) and EPIC-NL (36·8 g/d; 95 % CI 20·0, 53·5). Genetically predicted milk intake was not associated with stroke (HR per 25 g/d 1·05; 95 % CI 0·94, 1·16) or CHD (1·02; 95 % CI 0·96, 1·08). In gene-outcome analyses, there was no association of rs4988235 with risk of stroke (OR 1·02; 95 % CI 0·99, 1·05) or CHD (OR 0·99; 95 % CI 0·95, 1·03). Current Mendelian randomisation analysis does not provide evidence for a causal inverse relationship between milk consumption and stroke or CHD risk.